High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$1.5M
$1,526,485
Total Sells (Filtered)
$5.1M
$5,074,529
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RAPP |
Rapport Therapeutics, Inc.
|
COO
Discretionary Sell
|
2026-03-05 | $58,265 | S | Form 4 |
|
RAPP
M
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
Other
2026-02-19
$10,800
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-19 | $10,800 | M | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -11.6%
|
2026-02-18 | $86,639 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $62,573 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $103,191 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $67,970 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17
$25,219
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-17 | $25,219 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17
$156,328
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-17 | $156,328 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17
$65,108
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-17 | $65,108 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-20 | $152,333 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -16.4%
|
2026-01-20 | $132,737 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-15
$5,480
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-01-15 | $5,480 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-15
$222,652
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-01-15 | $222,652 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $18,622 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $83,862 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $70,393 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $72,722 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $15,985 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $61,925 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-15
$230,711
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-15 | $230,711 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-15
$24,419
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-15 | $24,419 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
COO
Other
|
2025-11-26 | $9,000 | M | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2025-11-26 | $150,486 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
COO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $55,850 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $77,715 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $69,216 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-17
$78,395
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-11-17 | $78,395 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-17
$135,696
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-11-17 | $135,696 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $72,267 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $31,001 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $119,539 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-10-15
$28,310
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-10-15 | $28,310 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-10-15
$190,887
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-10-15 | $190,887 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $19,760 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $111,429 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $1,037,101Large | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $37,624 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -42.7%
|
2025-09-17 | $917,542 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $18,930 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-09-15
$121,761
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-09-15 | $121,761 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-09-15
$83,888
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-09-15 | $83,888 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-09-12 | $499,374 | P | Form 4 |
|
RAPP
P
Rapport Therapeutics, Inc.
PAUL STEVEN M
• Director
Discretionary BuyΔOwn +47.3%
2025-09-12
$334,165
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +47.3%
|
2025-09-12 | $334,165 | P | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-09-12 | $692,947 | P | Form 4 |